152
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

ITGA9 Inhibits Proliferation and Migration of Dermal Microvascular Endothelial Cells in Psoriasis

, , , , , , , , & ORCID Icon show all
Pages 2795-2806 | Received 21 Oct 2022, Accepted 09 Dec 2022, Published online: 20 Dec 2022

References

  • Lowes MA, Bowcock AM, Krueger JG. Pathogenesis and therapy of psoriasis. Nature. 2007;445(7130):866–873. doi:10.1038/nature05663
  • Bhushan M, Mclaughlin B, Weiss JB, Griffiths CE. Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth factor are elevated in psoriasis. Br J Dermatol. 1999;141(6):1054–1060. doi:10.1046/j.1365-2133.1999.03205.x
  • Li J, Hou H, Zhou L, et al. Increased angiogenesis and migration of dermal microvascular endothelial cells from patients with psoriasis. Exp Dermatol. 2021;30(7):973–981. doi:10.1111/exd.14329
  • Romero MR, Carroll JM, Watt FM. Analysis of cultured keratinocytes from a transgenic mouse model of psoriasis: effects of suprabasal integrin expression on keratinocyte adhesion, proliferation and terminal differentiation. Exp Dermatol. 1999;8(1):53–67. doi:10.1111/j.1600-0625.1999.tb00348.x
  • Teige I, Backlund A, Svensson L, Kvist PH, Petersen TK, Kemp K. Induced keratinocyte hyper-proliferation in alpha2beta1 integrin transgenic mice results in systemic immune cell activation. Int Immunopharmacol. 2010;10(1):107–114. doi:10.1016/j.intimp.2009.10.004
  • Creamer D, Allen M, Sousa A, Poston R, Barker J. Altered vascular endothelium integrin expression in psoriasis. Am J Pathol. 1995;147(6):1661–1667.
  • Gal B, Dulic S, Kiss M, et al. Increased circulating anti-α6-integrin autoantibodies in psoriasis and psoriatic arthritis but not in rheumatoid arthritis. J Dermatol. 2017;44(4):370–374. doi:10.1111/1346-8138.13667
  • Sun G, Guillon E, Holley SA. Integrin intra-heterodimer affinity inversely correlates with integrin activatability. Cell Rep. 2021;35(10):109230. doi:10.1016/j.celrep.2021.109230
  • Bhatwadekar AD, Kansara V, Luo Q, Ciulla T. Anti-Integrin therapy for retinovascular diseases. Expert Opin Investig Drugs. 2020;29(9):935–945. doi:10.1080/13543784.2020.1795639
  • Hynes RO. A reevaluation of integrins as regulators of angiogenesis. Nat Med. 2002;8(9):918–921. doi:10.1038/nm0902-918
  • Shimaoka M, Springer TA. Therapeutic antagonists and conformational regulation of integrin function. Nat Rev Drug Discov. 2003;2(9):703–716. doi:10.1038/nrd1174
  • Han QX, Niu XP, Hou RX, et al. Dermal mesenchymal stem cells promoted adhesion and migration of endothelial cells by integrin in psoriasis. Cell Biol Int. 2021;45(2):358–367. doi:10.1002/cbin.11492
  • Sepp NT, Li LJ, Lee KH, et al. Basic fibroblast growth factor increases expression of the alpha v beta 3 integrin complex on human microvascular endothelial cells. J Invest Dermatol. 1994;103(3):295–299. doi:10.1111/1523-1747.ep12394617
  • Khan Z, Marshall JF. The role of integrins in TGFβ activation in the tumour stroma. Cell Tissue Res. 2016;365(3):657–673. doi:10.1007/s00441-016-2474-y
  • Zheng W, Jiang C, Li R. Integrin and gene network analysis reveals that ITGA5 and ITGB1 are prognostic in non-small-cell lung cancer. Onco Targets Ther. 2016;9:2317–2327. doi:10.2147/OTT.S91796
  • Mostovich LA, Prudnikova TY, Kondratov AG, et al. Integrin alpha9 (ITGA9) expression and epigenetic silencing in human breast tumors. Cell Adh Migr. 2011;5(5):395–401. doi:10.4161/cam.5.5.17949
  • Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–297. doi:10.1016/S0092-8674(04)00045-5
  • Farh KH, Grimson A, Jan C, et al. The widespread impact of mammalian microRNAs on mRNA repression and evolution. Science. 2005;310(5755):1817–1821. doi:10.1126/science.1121158
  • Lovendorf MB, Skov L. miRNAs in inflammatory skin diseases and their clinical implications. Expert Rev Clin Immunol. 2015;11(4):467–477. doi:10.1586/1744666X.2015.1020301
  • Moles R. MicroRNAs-based therapy: a novel and promising strategy for cancer treatment. Microrna. 2017;6(2):102–109. doi:10.2174/2211536606666170710183039
  • Archid R, Patzelt A, Asschenfeldt BL, et al. Confocal laser-scanning microscopy of capillaries in normal and psoriatic skin. J Biomed Opt. 2012;17(10):101511. doi:10.1117/1.JBO.17.10.101511
  • Boer OD, Wakelkamp IM, Pals ST, Claessen N, Bos JD, Daset PK. Increased expression of adhesion receptors in both lesional and non-lesional psoriatic skin. Arch Dermatol Res. 1994;286(6):304–311. doi:10.1007/BF00402220
  • Timis TL, Orasan R. Understanding psoriasis: role of miRNAs. Biomed Rep. 2018;9(5):367–374. doi:10.3892/br.2018.1146
  • Sileno S, Beji S, Agostino M, Carassiti A, Melillo G, Magenta A. microRNAs involved in psoriasis and cardiovascular diseases. Vasc Biol. 2021;3(1):49–68. doi:10.1530/VB-21-0007
  • Hawkes JE, Nguyen GH, Fujita M, et al. microRNAs in Psoriasis. J Invest Dermatol. 2016;136(2):365–371. doi:10.1038/JID.2015.409
  • Joyce CE, Zhou X, Xia J, et al. Deep sequencing of small RNAs from human skin reveals major alterations in the psoriasis miRNAome. Hum Mol Genet. 2011;20(20):4025–4040. doi:10.1093/hmg/ddr331
  • Sonkoly E, Wei T, Janson PC, et al. MicroRNAs: novel regulators involved in the pathogenesis of psoriasis? PLoS One. 2007;2(7):610. doi:10.1371/journal.pone.0000610
  • Zibert JR, Lovendorf MB, Litman T, Olsen J, Kaczkowski B, Skov L. MicroRNAs and potential target interactions in psoriasis. J Dermatol Sci. 2010;58(3):177–185. doi:10.1016/j.jdermsci.2010.03.004
  • Xia P, Fang X, Zhang ZH, et al. Dysregulation of miRNA146a versus IRAK1 induces IL-17 persistence in the psoriatic skin lesions. Immunol Lett. 2012;148(2):151–162. doi:10.1016/j.imlet.2012.09.004
  • Meisgen F, Landen NX, Wang A, et al. MiR-146a negatively regulates TLR2-induced inflammatory responses in keratinocytes. J Invest Dermatol. 2014;134(7):1931–1940. doi:10.1038/jid.2014.89
  • Lovendorf MB, Mitsui H, Zibert JR, et al. Laser capture microdissection followed by next-generation sequencing identifies disease-related microRNAs in psoriatic skin that reflect systemic microRNA changes in psoriasis. Exp Dermatol. 2015;24(3):187–193. doi:10.1111/exd.12604
  • O’Connell RM, Rao DS, Baltimore D. microRNA regulation of inflammatory responses. Annu Rev Immunol. 2012;30:295–312. doi:10.1146/annurev-immunol-020711-075013
  • Susini BG, Varner JA. Roles of integrins in tumor angiogenesis and lymphangiogenesis. Lymphat Res Biol. 2008;6(3–4):155–163. doi:10.1089/lrb.2008.1011
  • Zhang YL, Xin X, Cai LB, et al. Integrin α9 suppresses hepatocellular carcinoma metastasis by Rho GTPase signaling. J Immunol Res. 2018;2018:1–11.
  • Yang Y, Enis D, Zheng H, et al. Cell adhesion mediated by VCAM-ITGα9 interactions enables lymphatic development. Arterioscler Thromb Vasc Biol. 2015;35(5):1179–1189. doi:10.1161/ATVBAHA.114.304997
  • Bazigou E, Xie S, Chen C, et al. Integrin-alpha 9 is required for fibronectin matrix assembly during lymphatic valve morphogenesis. Dev Cell. 2009;17(2):175–186. doi:10.1016/j.devcel.2009.06.017